Resveratrol has been in the news recently as a possible treatment for obesity. It appears to increase lipolysis and the activity of glycogen synthase, whilst decreasing fatty acid synthesis and the activity of glycogen phosphorylase. How does the action of resveratrol compare to the actions of insulin and glucagon?